From the Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
From the Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona
AJNR Am J Neuroradiol. 2022 Aug;43(8):1148-1151. doi: 10.3174/ajnr.A7572. Epub 2022 Jul 21.
Middle meningeal artery embolization after surgical evacuation of a chronic subdural hematomas is associated with fewer treatment failures than surgical evacuation. We compared emergency department visits within 30 days for patients with chronic subdural hematomas with and without adjunctive middle meningeal artery embolization.
All cases of chronic subdural hematoma treated from January 1, 2018, through December 31, 2020, were retrospectively reviewed. Treatment was classified as surgery only or surgery combined with middle meningeal artery embolization. The primary outcome was 30-day emergency department presentation and readmission.
Of 137 patients who met the study criteria, 28 (20%) underwent surgery combined with middle meningeal artery embolization. Of these 28 patients, 15 (54%) underwent planned middle meningeal artery embolization and 13 (46%) underwent embolization after surgical failure. The mean chronic subdural hematoma size at presentation in the group with surgery only ( = 109, 20.5 [SD, 6.9] mm) was comparable with that in the combined group ( = 28, 18.7 [SD, 4.5] mm; = .16). A significantly higher percentage of the surgery-only group presented to the emergency department within 30 days compared with the combined group (32 of 109 [29%] versus 2 of 28 [7%] patients; = .02). No significant difference was found with respect to readmission (16 [15%] versus 1 [4%] patient; = .11). Nine patients (8%) in the surgery-only group were readmitted for significant reaccumulation or residual subdural hematoma compared with only 1 patient (4%) in the combined group ( = .40).
Surgical evacuation combined with middle meningeal artery embolization in patients with chronic subdural hematoma is associated with fewer 30-day emergency department visits compared with surgery alone.
与单纯手术清除相比,慢性硬脑膜下血肿术后行脑膜中动脉栓塞治疗,其治疗失败率更低。我们比较了伴或不伴脑膜中动脉栓塞的慢性硬脑膜下血肿患者在术后 30 天内行急诊就诊的情况。
回顾性分析了 2018 年 1 月 1 日至 2020 年 12 月 31 日所有接受慢性硬脑膜下血肿治疗的病例。治疗分为单纯手术治疗或手术联合脑膜中动脉栓塞治疗。主要结局为 30 天内急诊就诊和再入院。
符合本研究标准的 137 例患者中,28 例(20%)接受了手术联合脑膜中动脉栓塞治疗。其中 15 例(54%)患者行计划性脑膜中动脉栓塞治疗,13 例(46%)患者在手术失败后行栓塞治疗。单纯手术组患者的慢性硬脑膜下血肿大小在就诊时平均为 109mm(20.5±6.9mm),与联合组(28mm,18.7±4.5mm;P=.16)相当。与联合组相比,单纯手术组患者在术后 30 天内行急诊就诊的比例显著更高(32/109[29%]比 2/28[7%];P=.02)。两组患者再入院率无显著差异(16/109[15%]比 1/28[4%];P=.11)。与联合组相比,单纯手术组仅有 1 例(4%)患者因大量再积聚或残留硬脑膜下血肿而再次入院,9 例(8%)患者因该情况再次入院(P=.40)。
与单纯手术清除相比,慢性硬脑膜下血肿患者行手术清除联合脑膜中动脉栓塞治疗可降低术后 30 天内行急诊就诊的比例。